公开(公告)号：US20190269609A1

公开(公告)日：2019-09-05

申请号：US15737808

申请日：2017-06-23

申请人： TIANJIN CHASE SUN PHARMACEUTICAL CO., LTD.

发明人： Xiaoqing YAO ,  Changhai SUN ,  Kai DONG ,  Chuan LI ,  Guiping ZHANG ,  Tianhao DONG ,  Jing CAO ,  Qiyun WANG ,  Xianjun LI ,  Junmin GAO ,  Mingzhen SUN

IPC分类号： A61K9/00 ,  A61K31/7048 ,  A61K31/192 ,  A61K31/235 ,  A61K31/353 ,  A61K36/65 ,  A61K31/513 ,  A61K31/52 ,  A61K31/198 ,  A61K31/7064 ,  A61K31/7076 ,  A61K31/194 ,  A61K36/28 ,  A61K31/708 ,  A61K31/343 ,  A61K36/236 ,  A61K36/232 ,  A61K36/537 ,  A61P31/04

摘要： The invention relates to the technical field of medicines, and particularly relates to a multi-component injection and preparation processes and applications thereof. In the present invention, the effective ingredients of safflower carthamus. Red Paeony Root, Ligusticum wallichii, radix salviae miltiorrhizae and Angelica sinensis are analyzed and a multi-component injection is prepared via the modern pharmaceutical preparation technology. The study proves that the multi-component injection of the invention has therapeutic effects on Sepsis.

公开(公告)号：US20210346281A1

公开(公告)日：2021-11-11

申请号：US17235126

申请日：2021-04-20

申请人： TIANJIN CHASE SUN PHARMACEUTICAL CO. LTD

发明人： Xiaoqing YAO ,  Changhai SUN ,  Kai DONG ,  Chuan LI ,  Guiping ZHANG ,  Tianhao DONG ,  Jing CAO ,  Qiyun WANG ,  Xianjun LI ,  Junmin GAO ,  Mingzhen SUN

IPC分类号： A61K9/00 ,  A61P31/04 ,  A61K31/192 ,  A61K31/194 ,  A61K31/198 ,  A61K31/235 ,  A61K31/343 ,  A61K31/353 ,  A61K31/513 ,  A61K31/52 ,  A61K31/7048 ,  A61K31/7064 ,  A61K31/7076 ,  A61K31/708 ,  A61K36/232 ,  A61K36/236 ,  A61K36/28 ,  A61K36/537 ,  A61K36/65 ,  A61K9/08 ,  A61K47/26 ,  A61K36/286

摘要： The invention relates to the technical field of medicines, and particularly relates to a multi-component injection and preparation processes and applications thereof. In the present invention, the effective ingredients of safflower Carthamus, Red Paeony Root, Ligusticum wallichii, radix salvia miltiorrhizae and Angelica sinensis are analyzed and a multi-component injection is prepared via the modem pharmaceutical preparation technology. The study proves that the multi-component injection of the invention has therapeutic effects on Sepsis.